Comparison of Endoscopic Resection and Surgery for Early Gastric Cancer With Undifferentiated Histological Type

Recruiting N/A Interventional Study
Stomach Cancer Undifferentiated Type Expanded Indication of Endoscopic Resection
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
19 – 75
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
708 (estimated)
Sponsor
National Cancer Center, Korea · Government
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This multi-center, randomized controlled trial is designed to evaluate clinical effectiveness and cost-effectiveness of ESD for undifferentiated type of EGC meeting the expanded indication compared with surgery.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Patients who are diagnosed with undifferentiated type EGC (signet ring cell carcinoma, poorly differentiated tubular adenocarcinoma, or poorly cohesive carcinoma) that meets the expanded indication of ESD 1) Tumor confined to the mucosa without ulcer, and size ≤2 cm on endosc…
Contacts

Il Ju Choi, MD, PhD

+82-31-920-2282

cij1224@ncc.re.kr

CONTACT

Young-Il Kim, MD, PhD

+82-31-920-1712

11996@ncc.re.kr

CONTACT